Skip to main content
Premium Trial:

Request an Annual Quote

New Products: GeneDx's Dilated Cardiomyopathy Panel; dbSNP Build 137

Premium

GeneDx has expanded its Dilated Cardiomyopathy Panel, for which it uses next-gen sequencing to look at genes associated with inherited forms of DCM. The company recently added 11 new genes to the panel, to assess a total of 38 genes. According to the company, the new additions are expected to increase the panel's detection rate by about 20 percent.


The National Center for Biotechnology Information has released dbSNP Build 137 of the human genome, available via ftp, here. Build 137 includes new submissions from the 1000 Genomes Project phase I release and also from the ClinSeq Sequencing Project.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.